ARMATA PHARMACEUTICALS, INC. Proceeds from Issuance of Private Placement
ARMATA PHARMACEUTICALS, INC. (ARMP) had Proceeds from Issuance of Private Placement of $45.00 million as of 2022-02-09, per its 10-K filed 2023-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2023-03-16
- ARMATA PHARMACEUTICALS, INC. proceeds from issuance of private placement for the quarter ending 2015-06-30 was $0.00.
- ARMATA PHARMACEUTICALS, INC. proceeds from issuance of private placement for the quarter ending 2015-03-31 was $13.00M.
- ARMATA PHARMACEUTICALS, INC. proceeds from issuance of private placement for fiscal 2014 was $13.00M.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2022-02-09 | $45.00M 10-K · filed 2023-03-16 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $13.00M 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | $13.00M 10-Q · filed 2015-11-16 | |||
| 2014-12-31 | $13.00M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |